1 completed, 1 recruiting, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Ct: new trials by email Literature Review of Ct trials Research Report on Ct
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial Biospecimen Collection, Computed Tomography, Cystectomy - Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma | Phase 4 | Recruiting | Mayo Clinic | 75 | 2025-01-08 | 2026-10-01 |
| An Investigational Scan (18F-Fluciclovine PET-CT) for the Measurement of Therapeutic Response in Patients With Metastatic Prostate Cancer Computed Tomography, Fluciclovine F18, Positron Emission Tomography - Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 4 | Terminated | M.D. Anderson Cancer Center | 2 | 2019-09-19 | 2025-01-16 |
| Prevention of Recurrence in Depression With Drugs and CT Cognitive Therapy, Medications - Depression | Phase 4 | Completed | Vanderbilt University | 452 | 2002-10-01 | 2017-05-30 |
Depression (1) · Prostatic Neoplasms (1) · Ureteral Neoplasms (1) · Urinary Bladder Neoplasms (1)
M.D. Anderson Cancer Center (1) · Mayo Clinic (1) · Vanderbilt University (1)
United States (3)
Gregory C Ravizzini (1) · Jacob J. Orme, MD, PhD (1) · Jan A. Fawcett, MD (1) · Paras H. Shah, MD (1) · Robert J. DeRubeis, PhD (1) · Steven D. Hollon, PhD (1)
PMID 25142196, PMID 31799993, PMID 31896529, PMID 33326891
R01MH060713 (1)